Innovate UK is streaming funds into a £1-million artificial intelligence (AI) research project to be delivered by the Medicines Discovery Catapult and two Cambridge-based firms with expertise in software/machine learning.
19th September 2018
A new report from NHS Digital shows that a decreasing number of children are being vaccinated against potentially deadly or life-altering diseases such as tetanus, diphtheria and polio
19th September 2018
The European Commission has approved Almirall’s Ilumetri for moderate-to-severe chronic plaque psoriasis.
19th September 2018
Actelion has unveiled new data showing that the first ever randomised, controlled clinical trial investigating Opsumit as potential treatment for portopulmonary hypertension (PoPH) hit its primary target.
19th September 2018
Allergan and Sosei are voluntarily suspending clinical development activities with HTL0018318 pending investigation of an unexpected toxicology finding in an animal study involving non-human primates.
18th September 2018
AstraZeneca has unveiled data from a Phase III extension trial highlighting the efficacy of biologic Fasenra as an add-on maintenance treatment in patients with severe eosinophilic asthma.
18th September 2018
Cancer Research UK is investing some £14 million into transforming the city of London into a “world-leading hub for cancer biotherapeutics”.
18th September 2018
Researchers are calling for 40,000 people with depression or anxiety in England to join an online study hoping to explore any genetic links to these conditions.
18th September 2018
Irish pharma Allergan is buying privately-held, clinical-stage US biotech Bonti for access to its novel, fast-acting neurotoxin programmes for aesthetic and therapeutic applications.
17th September 2018
The National Institute for Health and Care Excellence has backed NHS funding for Novartis’ oral targeted adjuvant combination therapy Tafinlar and Mekinist, offering new hope to patients with a specific type of skin cancer.
17th September 2018
US regulators have approved Teva’s Ajovy for the preventative treatment of migraine in adults.
17th September 2018
AstraZeneca has unveiled late-stage data backing use of its triple combination therapy PT010 in patients with chronic obstructive pulmonary disease (COPD).
17th September 2018
Medical Science Liaison of the Year has been expanded to include three levels of seniority and forms the backbone of the all new Medical and Scientific Excellence Awards, alongside categories for scientific advisors and medical information professionals.
14th September 2018
ViiV Healthcare has submitted an application in Europe for a single-tablet, two-drug regimen of dolutegravir (DTG) and lamivudine (3TC) for the treatment of HIV-1 infection.
14th September 2018
Alarm bells over the NHS’ ability to cope with looming winter pressures are ringing again after some aspects of service performance sunk to new lows in the summer, with record waiting times for A&E and cancer treatment.
14th September 2018
